|
|
||||||||
Eur J Cardiothorac Surg 1999;15:75-83
© 1999 Elsevier Science NL
Cardiac Surgical Research and Cardiothoracic Surgery, The Rayne Institute, St. Thomas' Hospital, London SE1 7EH, UK
Received 10 August 1998; received in revised form 2 November 1998; accepted 11 November 1998.
Corresponding author. Tel.: +44-171-261-0157; fax: +44-171-928-0658; e-mail: d.chambers@umds.ac.uk
Objective: Myocardial protection with blood cardioplegia during cardiac surgery is increasingly preferred, but few studies have compared the protective effects of crystalloid cardioplegia to the same solution with blood as the only variable. This clinical study compared the protective effects of crystalloid or blood-based St. Thomas' Hospital cardioplegic solution No. 1. Methods: Fifty higher risk patients undergoing elective coronary artery bypass surgery, with an ejection fraction less than 40%, were randomly allocated to receive cold (4°C) intermittent crystalloid St. Thomas' No. 1 cardioplegia (n=25), or a similar blood-based solution (n=25) with a haematocrit of 1012%. We determined (1) peri-operative and post-operative arrhythmias, (2) left and right ventricular function (24 h) using the thermodilution technique, (3) left ventricular high-energy phosphate content sampled before ischaemia, the end of ischaemia and the end of bypass. Results: Pre-operative haemodynamic data, aortic cross-clamp and bypass times were similar in both groups of patients; there was no mortality. At the end of ischaemia there were no differences in ATP content between groups but creatine phosphate was maintained at a significantly (P<0.007) higher level in the blood-based St. Thomas' cardioplegia group than the crystalloid St. Thomas' cardioplegia group (20±2 (SE) vs. 13±1 µmol/g dry wt, respectively). Return to spontaneous sinus rhythm was significantly (P=0.002) increased in the blood-based St. Thomas' cardioplegia group (96%) compared to the crystalloid St. Thomas' cardioplegia group (60%). Early post-operative ventricular dysfunction occurred in both groups, but normal LV function (stroke work index) recovered significantly (P=0.043) more rapidly (by 2 h) in the blood-based St. Thomas' cardioplegia group of patients. Conclusions: In a higher risk (EF<40%) group of patients undergoing elective cardiac surgery, addition of blood to an established crystalloid cardioplegic solution significantly enhanced myocardial protection by reducing arrhythmias, improving rate of recovery of function and maintaining myocardial high-energy phosphate content during ischaemia.
Key Words: Patients Cardioplegia Myocardial protection Function Arrhythmias Metabolism
This article has been cited by other articles:
![]() |
M. F. Ibrahim and A. A. Refaat Long-term outcome after coronary artery bypass grafting in patients with left ventricular dysfunction: does the type of cardioplegia matter? Interactive CardioVascular and Thoracic Surgery, June 1, 2008; 7(3): 498 - 498. [Full Text] [PDF] |
||||
![]() |
S. Jacob, A. Kallikourdis, F. Sellke, and J. Dunning Is blood cardioplegia superior to crystalloid cardioplegia? Interactive CardioVascular and Thoracic Surgery, June 1, 2008; 7(3): 491 - 498. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Guru, J. Omura, A. A. Alghamdi, R. Weisel, and S. E. Fremes Is Blood Superior to Crystalloid Cardioplegia?: A Meta-Analysis of Randomized Clinical Trials Circulation, July 4, 2006; 114(1_suppl): I-331 - I-338. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. Bjerrum, M. J. Perko, and B. Beck Myocardial oxygen tension during surgical revascularization: A clinical comparison between blood cardioplegia and crystalloid cardioplegia Eur. J. Cardiothorac. Surg., February 1, 2006; 29(2): 181 - 185. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Amark, H. Berggren, K. Bjork, A. Ekroth, R. Ekroth, K. Nilsson, and J. Sunnegardh Blood Cardioplegia Provides Superior Protection in Infant Cardiac Surgery Ann. Thorac. Surg., September 1, 2005; 80(3): 989 - 994. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Ovrum, G. Tangen, S. Tollofsrud, R. Oystese, M. A. L. Ringdal, and R. Istad Cold blood cardioplegia versus cold crystalloid cardioplegia: A prospective randomized study of 1440 patients undergoing coronary artery bypass grafting J. Thorac. Cardiovasc. Surg., December 1, 2004; 128(6): 860 - 865. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Khan, C. Bianchi, P. Voisine, J. Feng, J. Baker, M. Hart, M. Takahashi, G. Stahl, and F. W. Sellke Reduction of myocardial reperfusion injury by aprotinin after regional ischemia and cardioplegic arrest J. Thorac. Cardiovasc. Surg., October 1, 2004; 128(4): 602 - 608. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kalawski, M. Majewski, E. Kaszkowiak, H. Wysocki, and T. Siminiak Transcardiac Release of Soluble Adhesion Molecules During Coronary Artery Bypass Grafting: Effects of Crystalloid and Blood Cardioplegia Chest, May 1, 2003; 123(5): 1355 - 1360. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. F. Kofoed, R. Bangsgaard, S. Carstensen, J. H. Svendsen, P. R. Hansen, H. Arendrup, B. Hesse, and H. Kelbaek Prolonged ischemic heart disease and coronary artery bypass -- relation to contractile reserve Eur. J. Cardiothorac. Surg., March 1, 2002; 21(3): 417 - 423. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |